dr. mohamad aimanuddin bin mohtar

pensyarah universiti

institut perubatan molekul (umbi)

No. rasmi:
UKM : 03 8921 5555
HUKM : 03-9145 6074/6075/6931/7748



   Biografi :
  • teck yew low, mohamad aimanuddin mohtar, mia yang ang and rahman jamal.  (2019).  connecting proteomics to ngs: proteogenomics and its current applications in biology.  - proteomics.  1-10. 

     

    m. aiman mohtar, teck yew low, borek vojtesek, rahman jamal and ted hupp.  (2019).  the development of a synthetic scfv monoclonal antibody targeting pro-oncogenic agr2.  - international conference on drug discovery and translational medicine 2018 (icddtm '18).  128. 

     

    saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  malaysian higher institution centres of excellence (hicoe) official compendium.  - 244. 

     

    m. aiman mohtar, lenka hernychova, robert o`neill, melanie lawrence, euan murray, borek vojtesek and ted r. hupp.  (2018).  the sequence-specific peptide-binding activity of the protein sulfide isomerase agr2 directs its` stable binding to the oncogenic receptor epcam.  - molecular & cellular proteomics. 

     

    m. aiman mohtar.  (2018).  crispr genome editing: my experience.  - crispr gene editing & multiplex immunoassay in conjunction with international conference on drug discovery and translational medicine 2018 (icddtm '18). 

     

    teck yew low, mohamad aimanuddin mohtar, mia yang ang and rahman jamal.  (2019).  connecting proteomics to ngs: proteogenomics and its current applications in biology.  - proteomics.  1-10. 

     

    m. aiman mohtar, lenka hernychova, robert o`neill, melanie lawrence, euan murray, borek vojtesek and ted r. hupp.  (2018).  the sequence-specific peptide-binding activity of the protein sulfide isomerase agr2 directs its` stable binding to the oncogenic receptor epcam.  - molecular & cellular proteomics. 

     
    Tiada Rekod
    Tiada Rekod
    Tiada Rekod
    Tiada Rekod

    saiful effendi syafruddin, mohamad aimanuddin mohtar, tan shing cheng, nadiah abu, nor aidatulakma abdullah@muda, nurul syakima ab mutalib, chin siok fong, neoh hui min, rahman jamal, nor azian abdul murad.  (2019).  malaysian higher institution centres of excellence (hicoe) official compendium.  - 244. 

     

    m. aiman mohtar, teck yew low, borek vojtesek, rahman jamal and ted hupp.  (2019).  the development of a synthetic scfv monoclonal antibody targeting pro-oncogenic agr2.  - international conference on drug discovery and translational medicine 2018 (icddtm '18).  128. 

     

    m. aiman mohtar, teck yew low, borek vojtesek, rahman jamal and ted hupp.  (2018).  frontiers in pharmacology.  - international conference on drug discovery and translational medicine 2018 (icddtm '18). 

     

    m. aiman mohtar, lenka hernychova, borek vojtesek, ted r. hupp.  (2018).  quantitative mass spectrometry analysis of agr2-reconstituted cancer cell identifies multiple agr2 interacting proteins.  - 8th regional conference on molecular medicine (rcmm) in conjunction with 4th national conference for cancer research (nccr). 

     

    m. aiman mohtar, rory duncan, borek vojtesek & ted r hupp.  (2018).  pro-oncogenic protein agr2 controls epcam expression and receptor presentation to the cell surface.  - stem cell and cancer symposium 2018. 

     

    m. aiman mohtar.  (2018).  crispr genome editing: my experience.  - crispr gene editing & multiplex immunoassay in conjunction with international conference on drug discovery and translational medicine 2018 (icddtm '18).